摘要 |
The invention concerns radiopharmaceutical products suitable for the selective labeling of lymphomas containing a metal complex with the formula:in which M is chosen from among 99mTc, 186Re and 188Re, and R1 represents an alkyl, cycloalkyl, aralkyl or aryl group, optionally substituted, obtained by reaction of a pertechnetate or a perrhenate with a reducing agent such as SnCl2ZP2O in the presence of a dithiocarboxylate having the formula: (R1CS2)-Z2+.
|